| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
From the Department of Anesthesiology, Magee-Womens Hospital, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.
Address correspondence to: Dr. Manuel C. Vallejo, Department of Anesthesiology, Magee-Womens Hospital, University of Pittsburgh, 300 Halket Street, Pittsburgh, PA 15213, USA. Phone: 412-641-4260; Fax: 412-641-4766; E-mail: vallejomc{at}anes.upmc.edu
| Abstract |
|---|
|
|
|---|
Methods: Lidocaine 1.5% with epinephrine 5 µgmL-1 was used for activation of LEA. Upon delivery plasma lidocaine concentrations were measured from the maternal vein (MV), neonatal umbilical vein (UV) and umbilical artery (UA) using TDx fluorescence polarization immunoassay.
Results: MV lidocaine concentrations were similar in both twin and singleton mothers. Both mean lidocaine UV and UA levels were 35% higher in twin A (first-delivered) compared to the singleton neonate, (P < 0.01, t test). Similarly, twin B mean UV and UA lidocaine levels were 35% and 53% higher than the singleton value (P < 0.01). Mean UV and UA lidocaine fetal/maternal ratios in both twins were at least 18% higher than the singleton value (P < 0.05).
Conclusion: Even though there were no differences in neonatal outcome, a potential does exist for high plasma lidocaine concentrations in twin fetuses, suggesting that the total maternal dose of lidocaine must be regulated carefully.
| Introduction |
|---|
|
|
|---|
Multiple gestation causes additional changes in maternal cardiac output and blood volume compared to singleton gestation. The purpose of this study is to determine the effect of twin pregnancy on maternal and fetal lidocaine levels compared to a singleton pregnancy.
| Methods |
|---|
|
|
|---|
At delivery, the maternal radial artery was sampled for blood gas analysis with a single stick using a #25 G needle. Maternal venous (MV) blood was collected from the antecubital vein and heparin was added as an anticoagulant. The specimen was centrifuged, plasma isolated and frozen at -20°C until analyzed for total plasma lidocaine concentration. Additionally, neonatal umbilical vein (UV) and umbilical artery (UA) samples were collected in heparin from the segment of a doubly clamped umbilical cord for measurement of blood pH, gas tensions and lidocaine levels. The umbilical cord of the first born (twin A) and the second born (twin B) were identified by placing one and two clamps on the respective umbilical cord. Neonatal Apgar scores and birth weights were also recorded.
Plasma lidocaine levels were measured using the TDx automated immunoassay method (Abbot Diagnostic, Eden Prairie, MN, USA) with a lower detection limit of 0.1 µgmL-1 and a cross-reactivity of < 0.05% to lidocaine metabolites.35 Compared to high pressure liquid chromatography, TDx immunoassay shows excellent correlation, with a reported correlation coefficient of 0.944, a slope of 0.975 and an intercept of 0.096.5 Fetal/maternal (F/M) lidocaine concentration ratios were calculated by dividing neonatal UV or UA lidocaine values by MV values for lidocaine.
| Statistical analysis |
|---|
|
|
|---|
| Results |
|---|
|
|
|---|
|
MV plasma lidocaine concentrations were not significantly different from each other in both the twin and singleton groups (Figure 1
). However, both UV and UA plasma lidocaine concentrations were significantly higher in both twins compared to the singleton neonate (P < 0.01, Figure 1
). Additionally, UA lidocaine concentration in twin B was significantly higher than in twin A (P < 0.01, Figure 1
). Regression analysis did not reveal correlation with respect to body mass index (BMI), UA and UV lidocaine concentrations.
|
|
|
| Discussion |
|---|
|
|
|---|
The reason for increased fetal UV and umbilical arterial lidocaine uptake in twins in our study was not related to any difference in maternal vein concentration because maternal vein lidocaine levels were not significantly different between the singleton and twin groups. Additionally, there was no difference in mean total dose of epidural lidocaine to establish anesthesia for Cesarean section between both groups. Furthermore, the higher twin maternal body weight could not account for higher fetal lidocaine levels because there was no correlation with respect to BMI and UA and UV lidocaine concentrations using regression analysis.
Why would twin fetuses have higher plasma lidocaine concentrations? It is well known that both heart rate and stroke volume are increased in twin pregnancies, especially during the third trimester, leading to a significant increase in cardiac output and cardiac index compared to singleton pregnancies.8 Additionally, the normal increase in plasma volume is expanded even more so in twin pregnancies.9,10 Likewise, the increase in uterine blood flow is greater than a singleton pregnancy and the uteroplacental unit is larger.9 The two placentas in twin gestations can act as a parallel low-resistance circuit, causing a fall in systemic vascular resistance with increased blood flow.9 Morris et al.11 found the mean clearance time of NaCl from the uterine muscle of twin pregnancies was 50% longer than in singleton pregnancies. The increase in cardiac output, plasma volume, as well as uterine blood flow in twin pregnancy can enhance lidocaine delivery to the larger twin fetoplacental unit. Amide local anesthetics like lidocaine are highly protein bound which limits placental transfer. However, maternal total protein levels drop considerably in twin pregnancy compared to singleton.10 Kennedy et al.12 identified maternal and fetal protein binding and blood pH as fundamental factors controlling fetal lidocaine levels. The drop in total serum protein in twin pregnancy increases the amount of free lidocaine available to the fetus.
Another factor for increased lidocaine levels in twins may be related to birth weight. As noted in this study, twin fetuses are normally smaller than singleton fetuses.13 Smaller body weight is associated with a lower volume of distribution and hence higher plasma fetal drug levels.2 Additionally, differences in oxygenation between twins and singleton are due to fetal weight.14 The transfer of oxygen across the placenta is blood-flow limited and the placenta supplies about 8 mL O2min-1kg-1 of fetal weight.14 In our study, mean singleton birth weight is greater than twin birth weight (Table II
), which explains the lower singleton UA oxygen tension.
Vascular communications, which are more likely to occur in a monochorionic placenta, can affect the amount of drug reaching either of the twin fetuses and thus affects the plasma concentration of drugs that cross the placenta from the maternal circulation. None of our twin neonates had any evidence of twin-to-twin transfusion such as anemia or vascular overload. In addition, most of our patients with a twin pregnancy had a dichorionic placenta.
Birth order influences the blood-gas status of twins.15,16 Both Fuchi and Young noted substantial differences between twin A and twin B with respect to their oxygenation with conditions consistently favouring twin A.15,16 Young et al.16 attributed the poor outcome in twin B to reduced uterine size following the delivery of twin A with decreased intervillous blood flow, and alteration in the placental volume produced by clamping the umbilical cord of twin A. Our results confirm Youngs results in that twin B had lower UV and UA pH and PO2 and higher PCO2. The decreased blood pH in twin B may also have contributed to higher lidocaine uptake due to decreased protein binding and increased ion trapping.1,17
No differences were noted with respect to uterine incision to delivery times between singleton and twin A deliveries. However, twin B delivery time was significantly longer compared to both singleton and twin A delivery times. The prolonged time interval in delivery of twin B may have accentuated the higher lidocaine F/M ratio in twin B, but this is clearly not the only reason for the increased lidocaine F/M levels in twins.
In conclusion, even though there were no clinical differences in neonatal outcome, it is important to realize that a potential does exist for high plasma lidocaine concentrations in twin fetuses and, therefore the total maternal dose of lidocaine must be carefully regulated. Further research is needed to assess local anesthetic concentrations in twin fetuses whose mothers receive continuous epidural infusion for prolonged periods of time for labour analgesia.
Revision received May 27, 2002. Accepted for publication March 7, 2002.
| References |
|---|
|
|
|---|
2 Wilkinson GR. Pharmacokinetics: the dynamics of drug absorption, distribution, and elimination. In: Hardman JG, Limbird LE, Gilman AG (Eds.). The Pharmacological Basis of Therapeutics, 10th ed. New York: McGraw-Hill, 2001: 329.
3 Caplan YH, Levine B. Application of the Abbott TDx lidocaine, phenytoin, and phenobarbital assays to postmortem blood specimens. J Anal Toxicol 1988; 12: 2657.[Medline]
4 Sedman AJ, Molitoris BA, Nakata LM, Gal J. Therapeutic drug monitoring in patients with chronic renal failure: evaluation of the Abbott TDxTM drug assay system. Am J Nephrol 1986; 6: 13234.[Medline]
5 Ramanathan J, Bottorff M, Jeter JN, Khalil M, Sibai BM. The pharmacokinetics and maternal and neonatal effects of epidural lidocaine in preeclampsia. Anesth Analg 1986; 65: 1206.[Medline]
6 Abboud TK, David S, Nagappala S, et al. Maternal, fetal, and neonatal effects of lidocaine with and without epinephrine for epidural anesthesia in obstetrics. Anesth Analg 1984; 63: 9739.
7 Abboud TK, Sarkis F, Blikian A, Varakian L, Earl S, Henriksen E. Lack of adverse neonatal neurobehavioral effects of lidocaine. Anesth Analg 1983; 62: 4735.
8 Veille JC, Morton MJ, Burry KJ. Maternal cardiovascular adaptations to twin pregnancy. Am J Obstet Gynecol 1985; 153: 2613.[Medline]
9 Gardner MO, Wenstrom KD. Maternal adaptation. In: Gall SA (Ed). Multiple Pregnancy and Delivery. St. Louis: Mosby-Year Book, Inc., 1996: 99109.
10 MacGillivray I, Campbell D, Duffus GM. Maternal metabolic response to twin pregnancy in primigravidae. J Obstet Gynaecol Br Commonw 1971; 78: 5304.[Medline]
11 Morris N, Osborn SB, Wright HP. Effective circulation of the uterine wall in late pregnancy. Measured with NaCl. Lancet 1955; 265: 3235.
12 Kennedy RL, Bell JU, Miller RP, et al. Uptake and distribution of lidocaine in fetal lambs. Anesthesiology 1990; 72: 4839.[Medline]
13 Grothe W, Ruttgers H. Twin pregnancies: an 11-year review. Acta Genet Med Gemellol (Roma) 1985; 34: 4958.[Medline]
14 Longo LD. Respiration in the fetal-placental unit. In: Cowett RM (Ed.): Principles of Perinatal-Neonatal Metabolism. New York: Springer-Verlag, 1991: 304.
15 Fuchi I, Noda K. Twin umbilical cord blood gas values. Acta Genet Med Gemellol 1992; 41: 13742.[Medline]
16 Young BK, Suidan J, Antoine C, Silverman F, Lustig I, Wasserman J. Differences in twins: the importance of birth order. Am J Obstet Gynecol 1985; 151: 91521.[Medline]
17 Nancarrow C, Runciman WB, Mather LE, Upton RN, Plummer JL. The influence of acidosis on the distribution of lidocaine and bupivacaine into the myocardium and brain of the sheep. Anesth Analg 1987; 66: 92535.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |